Reply: Comments on Stromal disrupting effects of nab-paclitaxel in pancreatic cancer

R. Alvarez; M. Musteanu; E. Garcia-Garcia; P. P. Lopez-Casas; D. Megias; C. Guerra; M. Muñoz; Y. Quijano; A. Cubillo; J. Rodriguez-Pascual; C. Plaza; E. De Vicente; S. Prados; S. Tabernero; M. Barbacid; F. Lopez-Rios; M. Hidalgo

doi:10.1038/bjc.2014.129

Reply: Comments on Stromal disrupting effects of nab-paclitaxel in pancreatic cancer

R. Alvarez, M. Musteanu, E. Garcia-Garcia, P. P. Lopez-Casas, D. Megias, C. Guerra, M. Muñoz, Y. Quijano, A. Cubillo, J. Rodriguez-Pascual, C. Plaza, E. De Vicente, S. Prados, S. Tabernero, M. Barbacid, F. Lopez-Rios, M. Hidalgo

School of Medicine

Research output: Contribution to journal › Letter › peer-review

2 Scopus citations

Original language	English (US)
Pages (from-to)	1677-1678
Number of pages	2
Journal	British journal of cancer
Volume	111
Issue number	8
DOIs	https://doi.org/10.1038/bjc.2014.129
State	Published - Oct 14 2014

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.1038/bjc.2014.129

Cite this

Alvarez, R., Musteanu, M., Garcia-Garcia, E., Lopez-Casas, P. P., Megias, D., Guerra, C., Muñoz, M., Quijano, Y., Cubillo, A., Rodriguez-Pascual, J., Plaza, C., De Vicente, E., Prados, S., Tabernero, S., Barbacid, M., Lopez-Rios, F., & Hidalgo, M. (2014). Reply: Comments on Stromal disrupting effects of nab-paclitaxel in pancreatic cancer. British journal of cancer, 111(8), 1677-1678. https://doi.org/10.1038/bjc.2014.129

Alvarez, R, Musteanu, M, Garcia-Garcia, E, Lopez-Casas, PP, Megias, D, Guerra, C, Muñoz, M, Quijano, Y, Cubillo, A, Rodriguez-Pascual, J, Plaza, C, De Vicente, E, Prados, S, Tabernero, S, Barbacid, M, Lopez-Rios, F & Hidalgo, M 2014, 'Reply: Comments on Stromal disrupting effects of nab-paclitaxel in pancreatic cancer', British journal of cancer, vol. 111, no. 8, pp. 1677-1678. https://doi.org/10.1038/bjc.2014.129

@article{bb89fa531dfc41f7b44cbc9ee4c39364,

title = "Reply: Comments on Stromal disrupting effects of nab-paclitaxel in pancreatic cancer",

author = "R. Alvarez and M. Musteanu and E. Garcia-Garcia and Lopez-Casas, {P. P.} and D. Megias and C. Guerra and M. Mu{\~n}oz and Y. Quijano and A. Cubillo and J. Rodriguez-Pascual and C. Plaza and {De Vicente}, E. and S. Prados and S. Tabernero and M. Barbacid and F. Lopez-Rios and M. Hidalgo",

note = "Funding Information: This study was supported by the Fondo de Investigaciones Sanitarias (FIS) PI10-01996 and Celgene Inc. to MH; the European Research Council (ERC-AG/250297-RAS AHEAD) and Spanish Ministry of Economy and Competitiveness (SAF2011-30173) to MB. Funding Information: LB is a recipient of APPICS predoctoral fellowship from the Departamento de Salud del Gobierno de Navarra. MC is a recipient of PFIS predoctoral fellowship from ISCIII. CM is a recipient of ANABASID from the Departamento de Educaci{\'o}n del Gobierno de Navarra.",

year = "2014",

month = oct,

day = "14",

doi = "10.1038/bjc.2014.129",

language = "English (US)",

volume = "111",

pages = "1677--1678",

journal = "British journal of cancer",

issn = "0007-0920",

publisher = "Nature Publishing Group",

number = "8",

}

TY - JOUR

T1 - Reply

T2 - Comments on Stromal disrupting effects of nab-paclitaxel in pancreatic cancer

AU - Alvarez, R.

AU - Musteanu, M.

AU - Garcia-Garcia, E.

AU - Lopez-Casas, P. P.

AU - Megias, D.

AU - Guerra, C.

AU - Muñoz, M.

AU - Quijano, Y.

AU - Cubillo, A.

AU - Rodriguez-Pascual, J.

AU - Plaza, C.

AU - De Vicente, E.

AU - Prados, S.

AU - Tabernero, S.

AU - Barbacid, M.

AU - Lopez-Rios, F.

AU - Hidalgo, M.

N1 - Funding Information: This study was supported by the Fondo de Investigaciones Sanitarias (FIS) PI10-01996 and Celgene Inc. to MH; the European Research Council (ERC-AG/250297-RAS AHEAD) and Spanish Ministry of Economy and Competitiveness (SAF2011-30173) to MB. Funding Information: LB is a recipient of APPICS predoctoral fellowship from the Departamento de Salud del Gobierno de Navarra. MC is a recipient of PFIS predoctoral fellowship from ISCIII. CM is a recipient of ANABASID from the Departamento de Educación del Gobierno de Navarra.

PY - 2014/10/14

Y1 - 2014/10/14

UR - http://www.scopus.com/inward/record.url?scp=84908885452&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84908885452&partnerID=8YFLogxK

U2 - 10.1038/bjc.2014.129

DO - 10.1038/bjc.2014.129

M3 - Letter

C2 - 24642623

AN - SCOPUS:84908885452

SN - 0007-0920

VL - 111

SP - 1677

EP - 1678

JO - British journal of cancer

JF - British journal of cancer

IS - 8

ER -

Reply: Comments on Stromal disrupting effects of nab-paclitaxel in pancreatic cancer

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this